期刊文献+

基于化学改性和切割方法的介入瓣瓣膜力学性能相关研究

Related Research on Mechanical Property of Valve Membrane in Transcatheter Bioprosthesis Valve Based on the Chemical Modification and Cutting Technology
原文传递
导出
摘要 本文探索了介入瓣瓣膜膜片的制备方法和瓣膜化学改性和切割方法对瓣膜膜片拉伸性能和缝合力力学性能的影响。本研究通过采集新鲜猪心包材料并应用碳化亚胺溶液和戊二醛溶液作为固定液的方法合成介入瓣瓣膜膜片材料;通过茚三酮法检测瓣膜膜片材料的交联度情况;应用拉伸及缝合力力学实验测试介入瓣瓣膜膜片材料的生物力学性能;通过场发射扫描电镜表征瓣膜膜片材料在经过缝合线拉伸作用后的胶原纤维取向分布。结果表明:经过化学改性后,介入瓣瓣膜膜片材料的交联度达到93.78%±3.2%;瓣膜膜片材料的拉伸强度达到(8.24±0.79)MPa;缝合力强度增加了102%。介入瓣瓣膜膜片材料具有较强的生物力学性能,有望发展成为的一种较好的介入瓣瓣膜膜片材料。 The aim of this research is to investigate the preparation method of valve membrane in transcatheter bioprosthetic valve, and to study the effect of chemical modification and cutting technology to tensile property and suture force property of valve membrane. We carried out a series of processes to perform the tests, such as firstly to test the crosslinking degree of valve membrane using ninhydrin method, then to test the tensile property and suture force property by using Instron's biomechanical testing equipment, and then to observe the collagen fiber orientation in valve membrane using Instron's biomechanical testing equipment and using field emission scanning electron microscopy. The study indicated that after the chemical modification, the crosslinking degree, tensile strength and suture force strength increasing rate of valve membrane were 93.78%±3.2%, (8.24± 0.79) MPa, 102%, respectively. The valve membrane had a better biomechanical property and would be expected to become valve membrane in transcatheter bioprosthesis valve.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2014年第4期801-805,共5页 Journal of Biomedical Engineering
基金 中国博士后科学基金资助项目(2011M500798) 上海市博士后科研资助计划重点项目资助(12R21421800) 上海市国际科技合作基金资助项目(10440707000)
关键词 介入瓣 瓣膜膜片 碳化亚胺 缝合力 transcatheter bioprosthetic valve valve membrane carbodiimide suture force
  • 相关文献

参考文献15

  • 1GREVE A M, BOMAN K, GOHI.KE-BAERWOLF C, et al. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study [J]. Circulation, 2012, 125(2): 346-353.
  • 2EWE S H, MURATORI M, DELGADO V, et al. Hemody- namic and clinical impact of prosthesis-patient mismatch after transcatheter aortic valve implantation [J]. J Am Coil Cardiol, 2011, 58(18): 1910-1918.
  • 3史嘉玮,董念国,孙宗全.RGD肽对天然瓣膜支架细胞黏附性能的影响[J].生物医学工程学杂志,2008,25(2):388-392. 被引量:4
  • 4PIAZZA N, DE JAEGERE P, SCHULTZ C, et al. Anatomy of the aortic valvar complex and its implications for transeath- eter implantation of the aortic valve [J]. Cite Cardiovasc In- terv, 2008, 1(1): 74-81.
  • 5KLAABORG K E, EGEBLAD H, JAKOBSEN C J, et al. Transapieal transeatheter treatment of a stenosed aortic valve bioprosthesis using the edwards SAPIEN transcatheter heart valve[J]. AnnThoraeSurg, 2009, 87(6): 1943-1946.
  • 6BAPAT V, THOMAS M, HANCOCK J, et al. First suc- cessful trans-catheter aortic valve implantation through as- cending aorta using Edwards SAPIEN THV system [J]. Eur J Cardiothorae Surg, 2010, 38(6): 811-813.
  • 7SHERIF M A, ABDEL-WAHAB M, STOCKER B, et al. Ana- tomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronie CoreValve bioprosthesis [J]. J Am Coil Cardiol, 2010, 56(20): 1623-1629.
  • 8JILAIHAWI H, CHIN D, SPYT T, et al. Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic-Corevalve bioprosthesis [J]. Eur Heart J, 2010, 31(7): 857-864.
  • 9EGGEBRECHT H, KAHLERT P, PATSALIS P, et al. De- velopments in transcatheter heart valves for patients with se- vere aortic stenosis [J]. Int Cardiol, 2011, 6(1): 58-61.
  • 10刘有军,乔爱科.基于血流动力学仿真的心血管外科手术规划进展[J].医用生物力学,2009,24(6):395-400. 被引量:10

二级参考文献59

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部